HNGZY'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Hangzhou Tigermed Consulting Co Ltd'in en son EPS'si $0.74 olup, $0.34 beklentilerini vurmak.
Hangzhou Tigermed Consulting Co Ltd HNGZY'ün son çeyrekteki geliri nasıl performans gösterdi?
Hangzhou Tigermed Consulting Co Ltd'in son çeyrek geliri $0.74
Hangzhou Tigermed Consulting Co Ltd'in gelir tahmini nedir?
2 Wall Street analistine göre, Hangzhou Tigermed Consulting Co Ltd'in gelir tahmini $1.94B ile $1.81B arasında değişmektedir.
Hangzhou Tigermed Consulting Co Ltd'in kazanç kalite puanı nedir?
Hangzhou Tigermed Consulting Co Ltd'in kazanç kalite puanı /'dir. Puan, karlılık, büyüme, nakit üretimi ve sermaye tahsisi ile kaldıraç olmak üzere dört boyuta dayanır.
Hangzhou Tigermed Consulting Co Ltd kazançlarını ne zaman rapor eder?
Hangzhou Tigermed Consulting Co Ltd'in bir sonraki kazanç raporu 2026-01-26'te bekleniyor
Hangzhou Tigermed Consulting Co Ltd'in beklenen kazançları nelerdir?
Wall Street analistlerine göre Hangzhou Tigermed Consulting Co Ltd'in beklenen kazançları $1.76B'dir.
Hangzhou Tigermed Consulting Co Ltd kazanç beklentilerini aştı mı?
Hangzhou Tigermed Consulting Co Ltd'in son kazançları $1.77B olup, beklentileri vuruş.
Önemli İstatistikler
Önceki Kapanış
$4
Açılış fiyatı
$4.28
Günün Aralığı
$4 - $4.28
52 haftalık aralık
$4 - $4.2
İşlem hacmi
612
Ort.Hacim
0
Dividend yield
--
EPS (TTM)
0.15
Piyasa Değeri
$3.4B
HANGZHOU TIGERMED CONSULTING CO nedir?
Hangzhou Tigermed Consulting Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Hangzhou, Zhejiang and currently employs 10,185 full-time employees. The company went IPO on 2012-08-17. Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The firm operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The firm conducts its businesses in the domestic and overseas markets.